A phase III follow-on study investigating 13-valent pneumococcal conjugate vaccine (PCV13) in children previously vaccinated with 4 doses of 7-valent or 13-valent pneumococcal conjugate vaccine

Trial Profile

A phase III follow-on study investigating 13-valent pneumococcal conjugate vaccine (PCV13) in children previously vaccinated with 4 doses of 7-valent or 13-valent pneumococcal conjugate vaccine

Completed
Phase of Trial: Phase III

Latest Information Update: 29 Dec 2015

At a glance

Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top